CAS RN: 169051-60-9

1,2-DIPALMITOYL-SN-GLYCERO-3-PHOSPHATE

Product Availability

Choose a grade to view its available package options.

11 package records10 with current stock4 grade groups
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20250402 100mg In stock Inquiry
Batchno.20250529 25mg In stock Inquiry
Batchno.20260308 500mg In stock Inquiry
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20260422 100mg In stock Shanghai Inquiry
Batchno.20260615 1g In stock Shanghai Inquiry
Batchno.20260303 250mg In stock Shanghai Inquiry
Batchno.20251020 50mg In stock Shanghai Inquiry
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20250109 100mg In stock Shanghai, Shandong Inquiry
Batchno.20250809 1g Out of stock 8-10 business days Inquiry
Batchno.20251204 250mg In stock Shanghai, Shandong, Hebei Inquiry
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20250319 250mg In stock Shanghai, Shandong Inquiry
  • Product code: starshine_CAS169051-60-9
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

169051-60-9 / sodium [(2R)-2,3-di(hexadecanoyloxy)propyl] hydrogen phosphate

Standard CAS: 169051-60-9 Multi CAS: No

Basic Information

CAS
169051-60-9
Multi CAS
No
Molecular Formula
C35H68NaO8P
Molecular Weight
670.900000
Exact Mass
670.454950
SMILES
CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)[O-])OC(=O)CCCCCCCCCCCCCCC.[Na+]
InChI
InChI=1S/C35H69O8P.Na/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-34(36)41-31-33(32-42-44(38,39)40)43-35(37)30-28-26-24-22-20-18-16-14-12-10-8-6-4-2;/h33H,3-32H2,1-2H3,(H2,38,39,40);/q;+1/p-1/t33-;/m1./s1
InChIKey
BMBWFDPPCSTUSZ-MGDILKBHSA-M

Computed Properties

Structural Parameters

Heavy atom count
45
Fraction Csp3
0.94
Rotatable bonds
34
H-bond acceptors
7
H-bond donors
1
Molar refractivity
177.24
TPSA
122.19

LogP / Solubility

WLOGP
6.89
MLOGP
6.12
XLogP3
6.89
Consensus LogP
6.63
Log S (ESOL)
-6.09
Class (ESOL)
Insoluble
Log S (Ali)
-10.03
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-13.82
Class (SILICOS-IT)
Insoluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-1.92

Drug-likeness / Medicinal Chemistry

Lipinski
No
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.17
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
5

Get In Touch

Contact Us